Search by Drug Name or NDC
NDC 55292-0322-60 Isturisa 10 mg/1 Details
Isturisa 10 mg/1
Isturisa is a ORAL TABLET, COATED in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Recordati Rare Diseases, Inc.. The primary component is OSILODROSTAT PHOSPHATE.
Product Information
NDC | 55292-0322 |
---|---|
Product ID | 55292-322_a135c232-1745-6ff6-e053-2a95a90acef1 |
Associated GPIs | 30022060600340 |
GCN Sequence Number | 080816 |
GCN Sequence Number Description | osilodrostat phosphate TABLET 10 MG ORAL |
HIC3 | P1G |
HIC3 Description | ADRENAL STEROID INHIBITORS |
GCN | 47795 |
HICL Sequence Number | 046396 |
HICL Sequence Number Description | OSILODROSTAT PHOSPHATE |
Brand/Generic | Brand |
Proprietary Name | Isturisa |
Proprietary Name Suffix | n/a |
Non-Proprietary Name | Osilodrostat |
Product Type | HUMAN PRESCRIPTION DRUG |
Dosage Form | TABLET, COATED |
Route | ORAL |
Active Ingredient Strength | 10 |
Active Ingredient Units | mg/1 |
Substance Name | OSILODROSTAT PHOSPHATE |
Labeler Name | Recordati Rare Diseases, Inc. |
Pharmaceutical Class | n/a |
DEA Schedule | n/a |
Marketing Category | NDA |
Application Number | NDA212801 |
Listing Certified Through | 2022-12-31 |
Package
NDC 55292-0322-60 (55292032260)
NDC Package Code | 55292-322-60 |
---|---|
Billing NDC | 55292032260 |
Package | 60 TABLET, COATED in 1 BLISTER PACK (55292-322-60) |
Marketing Start Date | 2020-03-31 |
NDC Exclude Flag | N |
Pricing Information | N/A |